LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
Authors
Keywords
-
Journal
NATURE CELL BIOLOGY
Volume 23, Issue 5, Pages 526-537
Publisher
Springer Science and Business Media LLC
Online
2021-05-07
DOI
10.1038/s41556-021-00672-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Long Non-coding RNAs in the Regulation of the Immune Response and Trained Immunity
- (2020) Manuel Flores-Concha et al. Frontiers in Genetics
- Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease
- (2019) Kyle Tretina et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
- (2019) Michal Harel et al. CELL
- Regulation of gene expression by cis-acting long non-coding RNAs
- (2019) Noa Gil et al. NATURE REVIEWS GENETICS
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression
- (2018) Qinyu Sun et al. TRENDS IN GENETICS
- Therapeutic Targeting of Long Non-Coding RNAs in Cancer
- (2018) Gayatri Arun et al. TRENDS IN MOLECULAR MEDICINE
- Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma
- (2018) Jing Sui et al. Cancer Medicine
- GENCODE reference annotation for the human and mouse genomes
- (2018) Adam Frankish et al. NUCLEIC ACIDS RESEARCH
- Regulation of the mammalian heat shock factor 1
- (2017) Sharadha Dayalan Naidu et al. FEBS Journal
- An atlas of human long non-coding RNAs with accurate 5′ ends
- (2017) Chung-Chau Hon et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
- (2017) Antje Sucker et al. Nature Communications
- HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
- (2017) Rina M. Mbofung et al. Nature Communications
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Interferon-induced guanylate-binding proteins in inflammasome activation and host defense
- (2016) Bae-Hoon Kim et al. NATURE IMMUNOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- HSF1: Guardian of Proteostasis in Cancer
- (2016) Chengkai Dai et al. TRENDS IN CELL BIOLOGY
- LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern
- (2016) T.-T. Sun et al. Cancer Discovery
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
- (2016) Tavi Nathanson et al. Cancer Immunology Research
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy
- (2015) D. A. Proia et al. Cancer Immunology Research
- Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
- (2014) Ryan A. Flynn et al. Cell Stem Cell
- Long non-coding RNAs in the regulation of the immune response
- (2014) James A. Heward et al. TRENDS IN IMMUNOLOGY
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Small Molecule Activators of the Heat Shock Response: Chemical Properties, Molecular Targets, and Therapeutic Promise
- (2012) James D. West et al. CHEMICAL RESEARCH IN TOXICOLOGY
- A Cluster of Interferon-γ-Inducible p65 GTPases Plays a Critical Role in Host Defense against Toxoplasma gondii
- (2012) Masahiro Yamamoto et al. IMMUNITY
- GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals
- (2012) A. R. Shenoy et al. SCIENCE
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Long noncoding RNAs: functional surprises from the RNA world
- (2009) J. E. Wilusz et al. GENES & DEVELOPMENT
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now